More information: Stefan D. Anker et al, Systematic review and meta-analysis of intravenous iron therapy for patients with heart failure and iron deficiency, Nature Medicine (2025). DOI: 10.1038 ...

Am J Health Syst Pharm. 2012;69(14):1206-1211. Mean ESA dosage requirements did not significantly differ between the i.v. and oral iron groups (41.6 and 33.5 units/kg/week, respectively), nor did ...

Among iron-deficient patients with heart failure with reduced ejection fraction (HFrEF), receiving intravenous iron supplementation was found to be safe but resulted in mixed findings, according ...

IV ferric carboxymaltose did not reduce time to first HF hospitalization or CV death vs. placebo for adults with HF and iron deficiency. Results were similar for those with transferrin saturation ...

CHICAGO, IL—Yet another trial of intravenous iron supplementation in chronic heart failure with reduced ejection fraction (HFrEF) has shown no significant impact in preventing patients from dying or ...

See what makes this violent game so popular » Edward Woo, a research analyst specializing in media and interactive entertainment at Wedbush Morgan Securities, said the game's release date and ...

Researchers looked at the effects of ferric carboxymaltose IV iron therapy on heart failure patients with iron deficiency using a sizable sample. According to the study's findings ...

Among iron-deficient patients with heart failure with reduced ejection fraction (HFrEF), receiving intravenous iron supplementation was found to be safe but resulted in mixed findings, according ...

Get Instant Summarized Text (Gist) Intravenous iron supplementation in iron-deficient patients with heart failure with reduced ejection fraction (HFrEF) showed mixed results. While it did not ...